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Introduction
Solar ultraviolet B (UV-B) radiation (280–315 nm) is the primary 
source of vitamin D for most humans, as UV-B penetrates the 
skin and converts 7-dehydrocholesterol to previtamin D3 and 
subsequently vitamin D3.
1,2 UV-B irradiance is hypothesized to 
impact breast carcinogenesis through resultant increases in cir-
culating levels of 25-hydroxyvitamin D (25(OH)D) and avail-
ability of this substrate in the epithelial tissues of the terminal 
ductal lobular unit of the breast.3 Although experimental studies 
have demonstrated biological plausibility in vitamin D inhibit-
ing cell proliferation and inducing apoptosis in breast cancer 
cells,4–7 results from previous population-based research exam-
ining the association between ambient UV exposure and breast 
cancer risk have been inconsistent, showing both inverse and 
null associations.8–14 A potential limitation of previous epidemi-
ologic studies that could have contributed to mixed findings has 
been the use of relatively coarse-scale UV exposure measures. 
For example, studies have linked geographic variables (e.g., 
Census tracts and cities) with National Aeronautics and Space 
Administration (NASA) Total Ozone Mapping Spectrometer 
(TOMS) UV satellite images (spatial resolution is approximately 
100 km2)8,10,11,13 and estimated UV during adulthood based on 
state at birth and state of longest residence.12 Although several 
of these studies showed no association between UV exposure 
and breast cancer,8,10–13 UV has been observed to exhibit sub-
stantial spatial and temporal variability;15,16 improved exposure 
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Background: Ultraviolet (UV) radiation exposure, the primary source of vitamin D for most people, may reduce breast cancer 
risk. To date, epidemiologic studies have shown inconsistent results.
Methods: The Nurses’ Health Study II is a U.S. nationwide prospective cohort of female registered nurses. A UV exposure model 
was linked with geocoded residential address histories. Early-life UV exposure was estimated based on the state of residence at birth, 
age 15, and age 30. Self-reported breast cancer was confirmed from medical records. Time-varying Cox regression models adjusted 
for established breast cancer risk factors were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).
Results: From 1989 to 2013, 3,959 invasive breast cancer cases occurred among 112,447 participants. Higher UV exposure during 
adulthood was not associated with invasive breast cancer risk overall (adjusted HR comparing highest to lowest quintile = 1.00; 
95% CI = 0.90, 1.11, P for trend = 0.64) or according to estrogen receptor (ER) status. There were suggestive inverse associations 
between ER− breast cancer and early-life UV exposure at birth (adjusted HR = 0.94; 95% CI = 0.88, 1.01 per interquartile range in-
crease [15.7 mW/m2]), age 15 (adjusted HR = 0.96; 95% CI = 0.89, 1.04 per 18.0 mW/m2), and age 30 (adjusted HR = 0.90; 95% 
CI = 0.82, 1.00 per 27.7 mW/m2).
Conclusions: Ambient UV exposure during adulthood was not associated with risk of invasive breast cancer overall or by ER status. 
However, we observed suggestive inverse associations between early-life UV exposure and ER− breast cancer risk.
 This is an open-access article distributed 
under the terms of the Creative Commons 
Attribution-Non Commercial-No Deriva-
tives License 4.0 (CCBY-NC-ND), where it 
is permissible to download and share the 
work provided it is properly cited. The work 
cannot be changed in any way or used 
commercially without permission from the 
journal.
What this study adds
Consistent with previous epidemiologic studies, this U.S. nation-
wide prospective cohort study showed that ambient ultraviolet 
(UV) radiation exposure during adulthood was not associated 
with invasive breast cancer risk. However, there were sugges-
tive inverse associations between early-life UV exposure and 
estrogen receptor-negative breast cancer, which warrants fur-
ther investigation as UV exposure during early life, a critical 
period regarding breast morphogenesis and differentiation, may 
be more relevant to breast carcinogenesis compared to expo-
sure later in life. Strengths of this study included a high spa-
tiotemporal resolution UV exposure assessment using updated 
geocoded residential addresses, examination of breast cancer 
subtypes, and extensive evaluation of potential confounding 
and effect modification.
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assessment for ambient UV with increased spatiotemporal res-
olution may reduce measurement error. The objective of this 
study was to examine the association between ambient UV 
exposure and breast cancer incidence in a prospective cohort 
of U.S. women using biennially updated geocoded residential 
address histories and a high spatiotemporal resolution UV ex-
posure model.
Methods
Study population
The Nurses’ Health Study II (NHSII) is an ongoing U.S. na-
tionwide prospective cohort study of 116,429 female registered 
nurses aged 25–42 years at baseline in 1989.15 Participants origi-
nally resided in California, Connecticut, Indiana, Iowa, Kentucky, 
Massachusetts, Michigan, Missouri, New York, North Carolina, 
Ohio, Pennsylvania, South Carolina, and Texas. As of the mid-
1990s, participants lived in all 50 states and Washington, D.C. 
Self-administered questionnaires were completed biennially to 
ascertain information regarding incident disease, medical his-
tory, diet, lifestyle factors, and health behaviors. Response rates 
for each questionnaire cycle are ≥90%.15 We excluded women 
who were missing exposure information due to residence out-
side of the contiguous US (where the UV exposure model was 
not available) or with prior diagnoses of other cancers (except 
nonmelanoma skin cancer). The study protocol was approved 
by the institutional review boards of Brigham and Women’s 
Hospital and Harvard T.H. Chan School of Public Health, and 
those of participating registries as required. Participants pro-
vided implied consent through returning questionnaires and in-
formed consent for release of medical records and collection of 
tissue specimens.
Assessment of outcome
Invasive breast cancer cases were identified through self-re-
port on biennial questionnaires. Deaths were reported by family 
members, U.S. Postal Service, or ascertained from the National 
Death Index. A medical record review was conducted to confirm 
breast cancer cases and abstract information regarding tumor 
characteristics. As 99% of breast cancer cases were confirmed 
via medical record review, self-reported cases without medical 
record confirmation were also included in the analysis. We also 
examined breast cancer subtypes defined by hormone receptor 
status based on tissue microarrays (TMAs) constructed at the 
Dana-Farber/Harvard Cancer Center Tissue Microarray Core 
Facility. Three 0.6 mm diameter cores from tumor tissue samples 
were inserted into TMA blocks. Immunohistochemical staining 
for markers including estrogen receptor (ER) was performed on 
5 μm paraffin sections cut from TMA blocks. Immunostained 
TMA sections were reviewed under a microscope and visually 
scored for ER positivity as determined by any nuclear staining 
(≥1%).16,17 If TMA information was unavailable, hormone re-
ceptor status was based on the medical record or pathology 
report.
Exposure assessment
Participant residential address histories updated every 2 years 
beginning in 1989 (Figure 1A) were geocoded to the street or 
ZIP Code level and spatially joined to a high spatiotemporal 
resolution erythemal UV exposure model (Figure  1B)18 in a 
geographic information system using ArcMap 10.5.1 (Esri, 
Redlands, California). Erythemal UV incorporates UV-A and 
UV-B wavelengths (the latter is involved in cutaneous vitamin 
D production) and weights these wavelengths based on their 
relative effectiveness to induce erythema on white skin.19,20 
Shorter UV-B wavelengths are weighted more in the erythemal 
UV calculation. The UV model was developed by applying 
area-to-point residual kriging to downscale NASA erythemal 
UV satellite remote sensing images from the TOMS and Ozone 
Monitoring Instrument satellite sensors.18 The UV model also 
incorporated information on established predictors of UV in-
cluding aerosol optical depth, cloud cover, elevation, ozone, 
and latitude.18,21 The UV model predicts average July noon-time 
erythemal UV irradiance (mW/m2), spanning the contiguous 
US, with a spatial resolution of 1 km2 and an annual temporal 
resolution that varied over time for each year from 1980 to 
2015. Model cross-validation demonstrated high predictive per-
formance, showing positive percent relative improvements in 
mean absolute error (0.6%–31.5%) and root mean square error 
(3.6%–29.4%) in UV exposure prediction compared to using 
TOMS or Ozone Monitoring Instrument satellite images only.18 
For each participant, UV exposure during adulthood was calcu-
lated as a time-varying cumulative average, where UV exposure 
from previous years was averaged and this average was updated 
every 2 years over the course of follow-up.
In secondary analyses, we examined UV exposure during 
early life. We lacked street address information for participant 
residences before cohort inception. Therefore, to estimate am-
bient UV exposure in early life, we linked the self-reported state 
of residence at birth, age 15, and age 30, with the UV expo-
sure model using geographic information system. The UV model 
was aggregated to the state level, where UV raster cell centroids 
intersecting a given state were averaged to calculate a mean state 
UV exposure value. For California residents, participants re-
ported living in Northern or Southern California; UV exposure 
was estimated using established boundaries.22 For participants 
who were born, age 15, or age 30 in years on or before 1980, we 
used the UV model estimates from 1980 (earliest available year). 
For participants who were born, age 15, or age 30 in years after 
1980, we used the UV model in the concurrent year.
Additional covariates
Individual-level data on variables including breast cancer risk 
factors were collected from biennial questionnaires (or every 
other questionnaire for diet and physical activity). Area-level 
variables, such as population density (to account for rural/urban 
differences in environmental exposures and access to health 
care), were ascertained by linking each participant’s locational 
information with Census tract-level data from the U.S. Census 
Bureau. Fine particulate matter air pollution <2.5 µm in diam-
eter (PM2.5) and coarse PM air pollution between 2.5 and 10 µm 
in diameter (PM2.5–10) exposures at each residential address were 
estimated by linking geocoded addresses with validated spatio-
temporal exposure models.23
Statistical analysis
Person-time accrued from June 1989 until the end of fol-
low-up in May 2013, incidence of invasive breast cancer or 
other cancer (excluding non-melanoma skin cancer, but in-
cluding in situ breast cancer), death, or loss to follow-up, 
whichever occurred first. Time-varying Cox regression models 
were used to calculate hazard ratios (HRs) and 95% confidence 
intervals (CIs) for the association between UV exposure and in-
cidence of invasive breast cancer. All models were stratified by 
age and questionnaire period. UV exposure was examined using 
quintiles (or tertiles for early-life UV exposure) and continu-
ously per interquartile range (IQR) increase. The IQR for UV 
exposure during adulthood was 30.0 and 15.7 mW/m2 (birth), 
18.0 mW/m2 (age 15), and 27.7 mW/m2 (age 30) for early life. 
Tests for trend were calculated using the median value of each 
quintile of exposure. Cubic regression splines were used to test 
for deviations from linearity. The missing indicator method was 
used to account for any missing covariates.
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The following established and suspected breast cancer risk 
factors were included in multivariable models a priori: age, 
race, family history of breast cancer, personal history of biop-
sy-confirmed benign breast disease, age at menarche, parity, age 
at first birth, lactation, menopausal status and hormone use 
(among postmenopausal women only), height, body mass index 
(BMI) at age 18, change in BMI since age 18, physical activity, 
adult alcohol consumption, total vitamin D intake (from diet 
and supplements), individual-level socioeconomic status (SES) 
(i.e., personal income, marital status, and living arrangements), 
area-level SES (i.e., Census tract median home value and median 
income), and population density. We also evaluated potential 
confounding by oral contraceptive use, screening mammog-
raphy, smoking status, alcohol consumption at age 15 and 18, 
Alternate Healthy Eating Index diet score,24 PM2.5, PM2.5–10, and 
sun exposure, sensitivity, and protection measures (number of 
sunburns from ages 15–20; hair color; sunscreen use as a teen-
ager; time in direct sunlight during summer months, winter 
Figure 1. (A) NHSII participant geocoded residential addresses (1989–2011) and (B) the spatiotemporal UV exposure model (1989–2011).
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months, high school/college, and ages 25–35; reaction to sun; 
and tanning booth use during high school/college, ages 25–35, 
and as an adult). However, as these variables did not change the 
effect estimate for UV exposure (i.e., ≥10% change in the HR), 
they were not included in the final model. We present results 
from a basic model, a parsimonious model, and a fully adjusted 
model.
We explored potential effect modification by race, meno-
pausal status, BMI, physical activity, total vitamin D intake, 
PM2.5, PM2.5–10, U.S. Census Bureau region of residence (i.e., 
Northeast, Midwest, West, and South), sun exposure, sen-
sitivity, and protection measures, and residential mobility. 
These variables have exhibited differential associations with 
either UV or subgroups of the population with higher risk 
or susceptibility for breast cancer.11,21,25,26 Effect modification 
was assessed by conducting stratified analyses using contin-
uous UV exposure. Tests for interaction were performed by 
adding interaction terms to the model and using likelihood 
ratio tests to determine statistical significance. All statistical 
analyses were conducted using SAS (SAS Institute, Cary, 
North Carolina).
Results
Table  1 shows population characteristics of the 112,447 par-
ticipants included in the analysis overall and by quintiles of 
cumulative average UV exposure over follow-up. Participants 
were on average 45.4 ± 8.3 years of age, consumed an average of 
385.0 ± 211.0 IU/day of vitamin D from diet and supplements, 
and were mostly white, premenopausal, married, parous, and 
never-smokers. The majority of participants over the course of 
follow-up resided in the Northeast and Midwest regions of the 
United States, and experienced at least one sunburn from ages 
15 to 20 years. Women residing in areas with higher UV lev-
els were more likely to live in the Western or Southern United 
States, to be nonwhite, never-smokers, nulliparous, have higher 
individual-level income, and live in areas with a higher Census 
tract median home value and income. Women in high-UV areas 
were also more likely to have had at least three sunburns from 
ages 15 to 20 years, spend ≤1 hour/week in direct sun during the 
summer months but ≥5 hours/week during the winter months, 
and to have ever moved during follow-up.
During 2,497,437 person-years of follow-up from 1989 to 
2013, 3,959 invasive breast cancers occurred (n = 2,368 ER+; 
n = 585 ER−). Higher levels of UV exposure during adulthood 
were not associated with invasive breast cancer risk overall 
(adjusted HR comparing highest to lowest quintile = 1.00; 
95% CI = 0.90, 1.11; P for trend = 0.64), or with ER+ and 
ER− breast cancer subtypes in multivariable models (Table 2). 
Results from the basic model adjusted for age and race did not 
substantially change after adjustment for SES factors in parsi-
monious models, or after additional adjustment for established 
breast cancer risk factors, total vitamin D intake, and popula-
tion density in fully adjusted models. We did not observe any 
statistically significant deviations from linearity. Similar null 
results were observed when examining UV exposure continu-
ously (Table 2) and in analyses among premenopausal women 
(see Supplemental Material, Table S1; http://links.lww.com/EE/
A49) and postmenopausal women (see Supplemental Material, 
Table S2; http://links.lww.com/EE/A49).
There were no statistically significant differences in the asso-
ciation between UV exposure and invasive breast cancer risk by 
race, menopausal status, BMI, physical activity, total vitamin D 
intake, PM2.5, PM2.5–10, region of residence, and sun exposure, 
sensitivity, and protection measures (see Supplemental Material, 
Table S3; http://links.lww.com/EE/A49). Similar null results 
were observed among participants who never moved compared 
to those who ever-moved during follow-up (see Supplemental 
Material, Table S4; http://links.lww.com/EE/A49).
Although we did not observe associations between ear-
ly-life UV exposure and invasive breast cancer risk overall, we 
did observe suggestive inverse associations with ER− breast 
cancer (Table 3). IQR increases in UV at birth (adjusted HR = 
0.94; 95% CI = 0.88, 1.01 per 15.7 mW/m2), age 15 (adjusted 
HR = 0.96; 95% CI = 0.89, 1.04 per 18.0 mW/m2), and age 30 
(adjusted HR = 0.90; 95% CI = 0.82, 1.00 per 27.7 mW/m2) 
were associated with slight decreases in ER− breast cancer risk.
Discussion
In this nationwide prospective analysis of US women, we did not 
observe an association between ambient UV exposure during 
adulthood and invasive breast cancer risk overall or according 
to subtypes defined by ER status. These results are consistent 
with several previous epidemiologic studies demonstrating null 
associations between UV and breast cancer.8–14 We also observed 
suggestive inverse associations between early-life UV exposure 
and ER− breast cancer.
Vitamin D derived from sun exposure is hypothesized to 
protect against breast cancer through mechanisms related to 
apoptosis, inhibition of cell proliferation, metastasis, and the 
synthesis and biological actions of estrogens.6 Breast tissue 
contains 1-α-hydroxylase, an enzyme required for production 
of the active vitamin D metabolite (1,25(OH)2D) from circu-
lating 25(OH)D.6 Locally synthesized 1,25(OH)2D can bind 
to vitamin D receptors, which are present in breast epithelium 
and thus play a role in regulating gene expression.27 Yet pop-
ulation-based studies examining vitamin D using blood, diet, 
self-reported sun exposure, and residence-based ambient UV 
measures have demonstrated inconsistent results with breast 
cancer risk.
Higher blood levels of circulating 25(OH)D have been associ-
ated with both inverse and null associations with breast cancer 
risk, where effect estimates ranged from 0.55 to 0.99.28–32 For 
example, a meta-analysis of 24 prospective cohort and nested 
case-control studies with 31,867 breast cancer cases found that 
higher levels of 25(OH)D in blood were not statistically signif-
icantly associated with breast cancer risk (pooled relative risk 
(RR) = 0.92; 95% CI = 0.83, 1.02).30 Although some observa-
tional studies and randomized controlled trials have shown that 
higher levels of vitamin D intake (dietary and/or supplemental) 
are associated with decreased risk for breast cancer, the ma-
jority of studies have not been associated with breast cancer risk 
(pooled RRs ranging from 0.91 to 1.11).28,30,33,34 Randomized 
controlled trials of vitamin D supplementation at a dose of 400 
IU/day combined with calcium supplementation (1,000 mg/day) 
or 2,000 IU/day did not significantly reduce breast cancer risk 
compared to the placebo group.35,36
Previous prospective and retrospective studies assess-
ing self-reported sun exposure and time spent outdoors have 
been mixed.8,9,11–14,37–40 In a retrospective case-control study in 
Ontario, Canada, >21 hours per week spent outdoors during 
ages 40–50 years compared to ≤6 hours per week was asso-
ciated with a 16% lower risk for breast cancer (adjusted odds 
ratio [OR] = 0.74; 95% CI = 0.61, 0.88).13 There was an in-
verse association between frequent recreational sun exposure 
(adjusted RR = 0.66; 95% CI = 0.44, 0.99) and occupational 
sun exposure (adjusted RR = 0.64; 95% CI = 0.41, 0.98) 
and breast cancer risk in the National Health and Nutrition 
Examination Survey I Epidemiologic Follow-up Study.12 In con-
trast, sun exposure (i.e., sunburns, sunbathing vacations, and 
tanning booth use) was not associated with breast cancer risk 
in the Women’s Lifestyle and Health Cohort Study in Sweden.37 
Time spent outdoors during early- and adult-life was not asso-
ciated with breast cancer risk in the United States Radiologic 
Technologists (USRT) study.11 However, time spent outdoors 
during the summer, other seasons, or year round was posi-
tively associated with postmenopausal breast cancer risk in the 
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Table 1
Age-adjusted characteristics of 112,447 NHSII women over follow-up from 1989 to 2013 by cumulative average UV quintile
Overall
UV quintile 1  
(<166.6  
mW/m2)
UV quintile 2  
(≥166.6–173.7  
mW/m2)
UV quintile 3  
(≥173.7–182.9  
mW/m2)
UV quintile 4  
(≥182.9–209.9  
mW/m2)
UV quintile 5  
(≥209.9 mW/m2)
Person-years (n) 2,497,437 500,327 500,537 503,207 500,037 493,329
Cumulative average UV (mW/m2) (mean ± SD) 186.4 ± 28.2 159.6 ± 12.2 168.9 ± 6.9 177.6 ± 4.8 193.2 ± 9.0 233.8 ± 17.4
Age (years) (mean ± SD) 45.4 ± 8.3 45.4 ± 8.2 45.3 ± 8.3 45.2 ± 8.3 45.1 ± 8.3 46.1 ± 8.2
White (%) 96 97 96 97 96 91
Family history of breast cancer (%) 11 10 11 11 10 11
Personal history of biopsy-confirmed benign  
breast disease (BBD) (%)
17 17 18 17 17 16
Menopausal status and hormone use (%)       
  Premenopausal 67 68 68 67 66 66
  Never users 5 6 6 6 4 4
  Past users 11 11 10 11 11 11
  Current users 8 7 6 7 9 10
  Missing 9 9 10 9 10 9
Age at menarche (years) (mean ± SD) 12.4 ± 1.4 12.4 ± 1.4 12.4 ± 1.4 12.4 ± 1.4 12.4 ± 1.4 12.4 ± 1.5
Parity and age at first birth (%)       
  Nulliparous 17 17 16 16 16 21
  1–2 children <25 14 14 14 15 16 13
  1–2 children ≥25–30 19 20 19 20 20 18
  1–2 children ≥30 13 12 12 12 12 15
  3+ children <25 11 12 12 13 11 8
  3+ children ≥25–30 10 11 11 11 9 8
  3+ children ≥30 2 2 2 2 2 2
  Missing 13 12 13 12 14 14
Breastfeeding (%)       
  Never 13 15 14 14 13 8
  Ever 55 55 54 56 54 55
  Missing 11 11 11 11 12 11
Oral contraceptive (OC) use (%)       
  Never 12 14 14 12 9 10
  Past 73 72 71 73 75 74
  Current 7 6 6 6 7 7
  Missing 9 8 9 8 9 9
Height (in) (mean ± SD) 64.9 ± 2.6 64.8 ± 2.6 64.8 ± 2.6 64.9 ± 2.6 64.9 ± 2.6 64.9 ± 2.7
BMI (kg/m2) at age 18 (mean ± SD) 21.2 ± 3.2 21.3 ± 3.2 21.3 ± 3.2 21.4 ± 3.2 21.2 ± 3.2 21.0 ± 2.9
Current BMI (kg/m2) (mean ± SD) 25.5 ± 4.9 25.6 ± 5.0 25.6 ± 4.9 25.6 ± 4.9 25.5 ± 5.0 25.0 ± 4.8
Smoking status (%)       
  Never 65 64 63 63 64 69
  Past 25 25 26 26 25 23
  Current 9 10 10 10 10 7
Alternate Healthy Eating Index (AHEI) (mean ± SD) 53.6 ± 10.8 52.8 ± 10.7 52.8 ± 10.7 53.1 ± 10.8 53.3 ± 10.7 56.0 ± 10.7
Total vitamin D intake (IU/day) (mean ± SD) 385.0 ± 211.0 382.9 ± 207.3 382.7 ± 206.4 384.0 ± 207.1 374.9 ± 206.1 401.1 ± 227.2
Adult alcohol consumption (g/day) (mean ± SD) 3.2 ± 5.2 2.9 ± 4.7 2.9 ± 4.8 3.2 ± 5.1 3.2 ± 5.3 3.6 ± 6.0
Physical activity (MET hours/week) (mean ± SD) 19.8 ± 27.9 20.1 ± 28.2 19.7 ± 28.4 19.8 ± 27.2 18.9 ± 27.0 20.5 ± 28.8
Census tract median home value ($10,000) (mean ± SD) 16.3 ± 12.1 14.8 ± 9.9 15.7 ± 11.6 13.8 ± 7.9 13.9 ± 9.1 23.4 ± 17.1
Census tract median income ($) (mean ± SD) 63,655 ± 23,808 63,610 ± 23,807 64,518 ± 24,431 61,948 ± 20,378 60,418 ± 22,067 67,880 ± 27,187
Individual-level income >$100,000 (%) 21 20 21 20 20 25
Married (%) 56 58 56 57 55 53
Living alone (%) 7 7 7 7 7 8
Region of residence (%)       
  Northeast 33 45 51 48 21 0
  Midwest 32 51 42 36 30 2
  West 15 0 0 1 7 68
  South 19 4 6 15 43 30
Cumulative average PM
2.5
 (10 µg/m3) (mean ± SD) 1.5 ± 0.3 1.6 ± 0.3 1.6 ± 0.3 1.5 ± 0.3 1.4 ± 0.3 1.4 ± 0.5
Cumulative average PM
2.5–10
 (10 µg/m3) (mean ± SD) 1.1 ± 0.5 0.9 ± 0.3 0.9 ± 0.3 0.8 ± 0.3 1.0 ± 0.3 1.6 ± 0.6
Population density (population/mi2) (mean ± SD) 3,767 ± 10,848 3,979 ± 12,766 5,991 ± 18,221 2,731 ± 6,893 1,866 ± 3,255 4,310 ± 4,973
No. sunburns from ages 15–20 (%)       
  0 35 37 36 35 34 34
  1 21 22 22 22 21 19
  2 17 17 17 17 18 17
  ≥3 26 24 24 25 28 30
Hair color (%)       
  Black 3 2 3 2 3 6
  Blonde 14 13 13 14 14 15
  Brown 66 69 68 68 65 61
  Red 3 3 3 3 4 3
  Missing 14 12 13 13 15 15
(Continued )
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Women’s Health Initiative Observational Study.8 These incon-
sistent findings may be related to recall bias from self-reported 
measures and/or assessing different measures of sun exposure 
(e.g., time spent outdoors versus sunburns) that may not ade-
quately capture vitamin D status.
Ambient UV exposure is a proxy measure of long-term vi-
tamin D status as solar UV-B is the primary source for vitamin 
D in most people.41 Approximately 90% of circulating levels of 
vitamin D come from solar UV-B.41 Ambient UV exposure has 
also been predictive of colorectal cancer risk.10,42 In this study, 
we were able to reconstruct historical ambient UV exposure 
through linking a spatially- and temporally-varying UV expo-
sure model with biennially updated residential addresses geo-
coded to the street or ZIP Code level starting in 1989. Although 
the UV exposure assessment in our study was an improvement 
compared to several previous studies that were limited to using 
coarse geographic variables (e.g., region of residence, city, study 
clinic), baseline address only, and/or low-resolution UV expo-
sure models, our null results were comparable to the majority of 
previous studies examining ambient UV exposure during adult-
hood and breast cancer incidence.8–13,40
In particular, several epidemiologic studies examining UV ex-
posure using NASA TOMS UV satellite images have shown no 
association with breast cancer risk.8,10,11,13 Specifically, UV expo-
sure based on the city of residence in Canada was not associated 
with breast cancer risk (n = 3,101 cases; adjusted OR = 0.99; 
95% CI = 0.83, 1.18).13 UV exposure estimated using the study 
clinic was not associated with postmenopausal breast cancer risk 
in Women’s Health Initiative Observational Study (n = 2,535 
cases).8 UV exposure from baseline residential Census tracts was 
not associated with breast cancer risk in the NIH-AARP Diet 
and Health Study (n = 8,681 cases; adjusted HR =1.03; 95% 
CI = 0.97, 1.09).10 Average lifetime combined UV, a measure 
incorporating UV estimated using the city of residence and the 
daily number of hours spent outdoors, was not associated with 
breast cancer risk in USRT (n = 716 cases; adjusted HR = 0.85; 
95% CI = 0.67, 1.08), although participants were exposed to 
relatively lower levels of UV in the USRT study compared to 
NHSII.11 In a study using an exposure model interpolated to 
a spatial resolution finer than 2.5° (≥276 km),43 UV exposure 
based on municipalities of residence was not associated with 
breast cancer risk in the Norwegian Women and Cancer Study 
Sunscreen use as teenager (%)       
  Not in sun 2 2 2 2 2 2
  <50% 66 67 66 67 65 64
  ≥50% 12 13 13 12 12 12
  Missing 20 18 19 19 21 21
Time in direct sun during summer months (%)       
  ≤1 hour/week 16 16 15 15 17 19
  2–4 hours/week 32 32 31 32 31 32
  ≥5 hours/week 23 24 24 24 22 20
  Missing 29 28 30 29 31 29
Time in direct sun during winter months (%)       
  ≤1 hour/week 36 41 39 39 34 26
  2–4 hours/week 26 24 25 25 26 31
  ≥5 hours/week 8 6 7 7 9 13
  Missing 30 28 30 29 31 30
Time in direct sun during high school/college (%)       
  ≤1 hour/week 5 5 5 5 5 5
  2–4 hours/week 23 23 22 23 23 22
  ≥5 hours/week 42 43 43 43 41 42
Missing 30 29 30 29 31 30
Time in direct sun from ages 25–35 (%)       
  ≤1 hour/week 6 6 6 6 6 7
  2–4 hours/week 29 29 28 29 29 29
  ≥5 hours/week 35 36 36 37 34 34
  Missing 30 29 30 29 32 30
Reaction to sun (%)       
  No reaction or some redness 53 53 53 53 54 53
  Burn or painful burn 47 47 47 47 46 47
Tanning booth use during high school/college (%)       
  None 64 65 64 64 62 64
  1–2 times/year 3 3 3 3 3 3
  ≥3 times/year 3 3 3 4 4 3
  Missing 30 28 30 29 31 30
Tanning booth use from ages 25–35 (%)       
  None 57 58 57 56 54 59
  1–2 times/year 5 5 5 6 6 5
  ≥3 times/year 8 8 8 9 9 6
  Missing 30 29 30 29 31 30
Tanning booth use during adulthood (%)       
  None 60 59 59 58 58 64
  1–2 times/year 3 3 3 3 3 2
  ≥3 times/year 8 9 8 9 8 4
  Missing 30 29 30 29 31 30
Ever-moved Census tract (%) 79 72 76 80 81 85
Table 1
(Continued )
Overall
UV quintile 1  
(<166.6 mW/
m2)
UV quintile 2  
(≥166.6–173.7 mW/ 
m2)
UV quintile 3  
(≥173.7–182.9  
mW/m2)
UV quintile 4  
(≥182.9–209.9  
mW/m2)
UV quintile 5  
(≥209.9 mW/m2)
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(n = 948 cases; adjusted RR = 1.17; 95% CI = 0.95, 1.44).9 
Studies assessing UV exposure in addition to other sun expo-
sure-related variables (e.g., time spent outdoors, sunscreen use, 
skin color, tanning booth use, sunburns) showed inverse and 
null associations.8,11,13,43 In particular, UV exposure was not as-
sociated with breast cancer risk in studies that adjusted for time 
spent outdoors.8,11,13 There was also little evidence of an associ-
ation when considering ER/PR status.8 In contrast to these stud-
ies suggesting no association, studies that have shown inverse 
associations between UV exposure and breast cancer have been 
ecological or used relatively coarser geographic variables to link 
UV exposure data compared to studies showing null results.44 
For example, there was an inverse association between higher 
UV exposure based on the region of residence at baseline and 
breast cancer risk in the French E3N cohort (n = 2,871 cases; 
adjusted HR = 0.91; 95% CI = 0.82, 0.99).40
In our study, we observed a suggestive inverse association 
between early-life UV exposure and ER− breast cancer. UV 
exposure during early life, a critical period regarding breast 
morphogenesis and differentiation during which the breast is 
highly sensitive to various influences, may be more relevant to 
breast carcinogenesis compared to UV exposure later in life as 
an adult.45 For example, atomic bomb radiation exposure during 
ages 10–19 years was associated with higher than expected 
breast cancer incidence compared to women exposed during 
adulthood.46 Exposure to radiation treatment for tuberculosis 
was associated with higher risk for breast cancer mortality, 
with the highest risk observed among those exposed between 
ages 10–14 years.47 Further, several epidemiologic studies have 
shown inverse associations between early-life UV exposure from 
self-report. Spending >21 hours/week outdoors during ages 
10–19 years (adjusted OR = 0.71; 95% CI = 0.60, 0.85) and 
20–39 years (adjusted OR = 0.64; 95% CI = 0.53, 0.76) was 
associated with a lower risk for breast cancer.13 Although the 
residence-based early-life UV exposure measures in that study 
showed no association with breast cancer, the authors noted 
limited exposure variability in Ontario, Canada.13 In another 
study conducted in Ontario, higher outdoor activity episodes 
(for at least 30 minutes between 9 am and 5 pm at least once per 
month from June to August) during ages 20–29 years were asso-
ciated with a lower risk for breast cancer (adjusted OR = 0.65; 
95% CI = 0.50, 0.85).48 Among wives of Agricultural Health 
Study participants, at least 1 hour of sun exposure per day 
10 years before enrollment (60.3% of participants were aged 
<50 years at enrollment) was associated with a decreased risk 
for breast cancer (adjusted HR = 0.8; 95% CI = 0.6, 1.0); this 
inverse association was also observed with ER+ but not ER− 
breast cancer.14 Sunbathing vacations between ages 10 and 29 
years as well as tanning booth use between ages 10 and 39 years 
were associated with decreased risks for breast cancer in the 
Swedish Women’s Lifestyle and Health Cohort.39 In our study, 
the early-life UV exposure measures were based on the state of 
residence and are subject to exposure misclassification. Further, 
the range for early-life UV exposure was lower than for cumu-
lative average UV exposure during adulthood. Future research 
assessing UV earlier in life before adulthood, such as from men-
arche to first pregnancy,49 and potential differential effects by 
breast cancer subtype is warranted.
These analyses include several limitations. We did not have 
information on variables affecting personal UV exposure in-
cluding time spent outdoors, clothing for sun protection, and 
seeking shade. However, we were able to account for several sun 
exposure, sensitivity, and protection measures collected from 
questionnaires. For example, results stratified by time in direct 
sun during summer as well as winter months were similarly null. 
However, there may be residual confounding as these measures 
may not adequately capture UV exposure-related behaviors. We 
also adjusted for physical activity, which is a proxy for time 
Table 2
Associations between cumulative average UV exposure during adulthood and breast cancer risk in NHSII from 1989 to 2013  
(n = 112,447)
Outcomea
Cases 
(n)
Person-years 
(n)
Basicb HR  
(95% CI)
Parsimoniousc  
HR (95% CI)
Fully adjustedd  
HR (95% CI)
Invasive breast cancer      
  UV quintile 1 790 500,327 Referent Referent Referent
  UV quintile 2 821 500,537 1.05 (0.95, 1.15) 1.05 (0.95, 1.16) 1.05 (0.95, 1.16)
  UV quintile 3 760 503,207 0.97 (0.88, 1.07) 0.98 (0.88, 1.08) 0.96 (0.87, 1.06)
  UV quintile 4 755 500,037 0.98 (0.89, 1.09) 1.00 (0.90, 1.11) 0.98 (0.88, 1.08)
  UV quintile 5 833 493,329 1.03 (0.93, 1.14) 1.04 (0.94, 1.15) 1.00 (0.90, 1.11)
  P for trend   0.86 0.79 0.64
  Continuous UV (per IQR increase)e 3,959 2,497,437 1.00 (0.97, 1.04) 1.01 (0.97, 1.05) 0.99 (0.96, 1.03)
ER+      
  UV quintile 1 460 500,642 Referent Referent Referent
  UV quintile 2 504 500,847 1.10 (0.97, 1.25) 1.10 (0.97, 1.25) 1.10 (0.97, 1.25)
  UV quintile 3 445 503,493 0.98 (0.86, 1.11) 0.98 (0.86, 1.12) 0.97 (0.85, 1.10)
  UV quintile 4 445 500,346 1.00 (0.88, 1.14) 1.02 (0.89, 1.16) 0.99 (0.87, 1.13)
  UV quintile 5 514 493,626 1.09 (0.96, 1.24) 1.07 (0.94, 1.22) 1.03 (0.90, 1.17)
  P for trend   0.45 0.71 0.73
  Continuous UV (per IQR increase)e 2,368 2,498,954 1.02 (0.97, 1.06) 1.01 (0.96, 1.06) 0.99 (0.95, 1.04)
ER−      
  UV quintile 1 120 500,972 Referent Referent Referent
  UV quintile 2 127 501,188 1.09 (0.85, 1.40) 1.10 (0.85, 1.41) 1.10 (0.86, 1.42)
  UV quintile 3 115 503,788 0.98 (0.75, 1.26) 0.98 (0.76, 1.27) 0.97 (0.75, 1.25)
  UV quintile 4 112 500,631 0.96 (0.74, 1.25) 0.98 (0.76, 1.27) 0.97 (0.75, 1.26)
  UV quintile 5 111 493,973 0.93 (0.72, 1.21) 0.98 (0.75, 1.29) 0.98 (0.74, 1.28)
  P for trend   0.31 0.58 0.54
  Continuous UV (per IQR increase)e 585 2,500,552 0.97 (0.89, 1.07) 1.00 (0.90, 1.10) 1.00 (0.90, 1.10)
aUV quintile 1: <166.6 mW/m2; quintile 2: ≥166.6–173.7 mW/m2; quintile 3: ≥173.7–182.9 mW/m2; quintile 4: ≥182.9–209.9 mW/m2; quintile 5: ≥209.9 mW/m2.
bAdjusted for age and race.
cAdditionally adjusted for Census tract median home value, Census tract median income, marital status, living arrangements, and individual-level income.
dAdditionally adjusted for family history of breast cancer, personal history of biopsy-confirmed BBD, age at menarche, parity, age at first birth, lactation, menopausal status and hormone use (among 
postmenopausal women only), height, BMI at age 18, change in BMI since age 18, physical activity, adult alcohol consumption, total vitamin D intake, and population density.
eAn IQR increase in cumulative average UV is 30.0 mW/m2.
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spent outdoors. Exposure measurement error may have im-
pacted study results as ambient UV exposure was estimated 
using geocoded residential addresses, which did not account 
for time-activity patterns around the workplace, outdoor 
recreational locations, or other locations. There may be low 
variability in time spent outdoors and ambient UV exposure in 
this study population,50 contributing to the null results. Further, 
early-life UV exposure was based on the state of residence, likely 
Table 3
Associations between early-life UV exposure according to state at birth, age 15, and age 30 and breast cancer risk in NHSII
Outcomea Cases (n)
Person-years 
(n)
Basicb HR  
(95% CI)
Parsimoniousc  
HR (95% CI)
Fully adjustedd  
HR (95% CI)
Invasive breast cancer      
  UV at birth      
   UV tertile 1 873 527,563 Referent Referent Referent
   UV tertile 2 1,335 763,853 1.03 (0.95, 1.12) 1.04 (0.95, 1.13) 1.04 (0.95, 1.13)
   UV tertile 3 965 578,424 1.00 (0.92, 1.10) 1.01 (0.92, 1.11) 0.99 (0.90, 1.08)
   P for trend   0.83 0.85 0.49
   Continuous UV (per IQR increase)e 3,173 1,869,840 1.00 (0.98, 1.03) 1.00 (0.98, 1.03) 0.99 (0.97, 1.02)
  UV at age 15      
   UV tertile 1 870 526,425 Referent Referent Referent
   UV tertile 2 1,312 756,440 1.02 (0.94, 1.12) 1.03 (0.95, 1.12) 1.03 (0.95, 1.13)
   UV tertile 3 991 586,974 1.01 (0.92, 1.11) 1.01 (0.92, 1.11) 0.99 (0.90, 1.08)
   P for trend   0.99 0.99 0.52
   Continuous UV (per IQR increase)e 3,173 1,869,840 1.00 (0.97, 1.02) 1.00 (0.97, 1.03) 0.99 (0.96, 1.02)
  UV at age 30      
   UV tertile 1 1,033 619,994 Referent Referent Referent
   UV tertile 2 1,111 648,144 1.11 (1.02, 1.21) 1.11 (1.02, 1.22) 1.10 (1.01, 1.20)
   UV tertile 3 1,029 601,702 1.08 (0.99, 1.18) 1.08 (0.98, 1.18) 1.05 (0.95, 1.15)
   P for trend   0.34 0.34 0.78
   Continuous UV (per IQR increase)e 3,173 1,869,840 1.01 (0.98, 1.05) 1.01 (0.97, 1.05) 1.00 (0.96, 1.03)
ER+      
  UV at birth      
   UV tertile 1 547 527,857 Referent Referent Referent
   UV tertile 2 824 764,337 1.01 (0.90, 1.12) 1.01 (0.91, 1.13) 1.02 (0.91, 1.13)
   UV tertile 3 571 578,802 0.95 (0.84, 1.07) 0.94 (0.83, 1.06) 0.92 (0.81, 1.03)
   P for trend   0.26 0.19 0.07
   Continuous UV (per IQR increase)e 1,942 1,870,996 1.00 (0.97, 1.03) 1.00 (0.97, 1.03) 0.99 (0.96, 1.02)
  UV at age 15      
   UV tertile 1 531 526,735 Referent Referent Referent
   UV tertile 2 813 756,906 1.03 (0.93, 1.15) 1.04 (0.93, 1.16) 1.04 (0.93, 1.16)
   UV tertile 3 598 587,355 1.00 (0.89, 1.12) 0.99 (0.88, 1.11) 0.96 (0.85, 1.08)
   P for trend   0.73 0.59 0.25
   Continuous UV (per IQR increase)e 1,942 1,870,996 1.00 (0.97, 1.03) 0.99 (0.96, 1.03) 0.99 (0.95, 1.02)
  UV at age 30      
   UV tertile 1 638 620,354 Referent Referent Referent
   UV tertile 2 659 648,582 1.10 (0.98, 1.24) 1.10 (0.99, 1.24) 1.09 (0.97, 1.22)
   UV tertile 3 645 602,061 1.14 (1.02, 1.27) 1.13 (1.00, 1.27) 1.09 (0.97, 1.22)
   P for trend   0.05 0.09 0.30
   Continuous UV (per IQR increase)e 1,942 1,870,996 1.04 (1.00, 1.09) 1.03 (0.99, 1.08) 1.02 (0.97, 1.07)
ER−      
  UV at birth      
   UV tertile 1 135 528,258 Referent Referent Referent
   UV tertile 2 194 764,900 0.98 (0.79, 1.23) 0.99 (0.80, 1.24) 1.00 (0.80, 1.25)
   UV tertile 3 139 579,207 0.94 (0.74, 1.19) 0.97 (0.76, 1.23) 0.96 (0.75, 1.22)
   P for trend   0.60 0.77 0.69
   Continuous UV (per IQR increase)e 468 1,872,365 0.94 (0.88, 1.01) 0.95 (0.88, 1.02) 0.94 (0.88, 1.01)
  UV at age 15      
   UV tertile 1 145 527,118 Referent Referent Referent
   UV tertile 2 181 757,482 0.86 (0.69, 1.07) 0.87 (0.69, 1.08) 0.88 (0.70, 1.09)
   UV tertile 3 142 587,765 0.87 (0.69, 1.10) 0.89 (0.71, 1.13) 0.89 (0.70, 1.12)
   P for trend   0.43 0.59 0.49
   Continuous UV (per IQR increase)e 468 1,872,365 0.96 (0.89, 1.03) 0.96 (0.89, 1.04) 0.96 (0.89, 1.04)
  UV at age 30      
   UV tertile 1 168 620,803 Referent Referent Referent
   UV tertile 2 167 649,042 0.97 (0.77, 1.21) 0.97 (0.77, 1.22) 0.96 (0.77, 1.21)
   UV tertile 3 133 602,521 0.79 (0.62, 1.00) 0.81 (0.63, 1.03) 0.79 (0.62, 1.01)
   P for trend   0.04 0.07 0.04
   Continuous UV (per IQR increase)e 468 1,872,365 0.90 (0.82, 0.99) 0.91 (0.82, 1.01) 0.90 (0.82, 1.00)
aFor UV exposure at birth and age 15–UV tertile 1: <164.6 mW/m2; tertile 2: ≥164.6–170.9 mW/m2; tertile 3: ≥170.9 mW/m2. For UV exposure at age 30–UV tertile 1: <170.9 mW/m2; tertile 2: 
≥170.9–186.5 mW/m2; tertile 3: ≥186.5 mW/m2.
bAdjusted for age and race.
cAdditionally adjusted for Census tract median home value, Census tract median income, marital status, living arrangements, and individual-level income.
dAdditionally adjusted for family history of breast cancer, personal history of biopsy-confirmed BBD, age at menarche, parity, age at first birth, lactation, hormone use (among postmenopausal women only), 
height, BMI at age 18, change in BMI since age 18, physical activity, adult alcohol consumption, total vitamin D intake, and population density.
eAn IQR increase in UV is 15.7 mW/m2 for birth, 18.0 mW/m2 for age 15, and 27.7 mW/m2 for age 30.
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leading to exposure misclassification error as UV levels vary 
within states. The generalizability of our results may be limited, 
as participants were predominantly white. Vitamin D insuffi-
ciency is more prevalent in black women, who are characterized 
by increased melanin that absorbs UV and reduces vitamin D 
production in the skin.26
Strengths of this study include a high spatiotemporal reso-
lution UV exposure assessment. Ambient UV was objectively 
estimated by linking biennially updated geocoded residential 
addresses with a validated UV exposure model that is, to date, 
the highest spatially and temporally resolved model of its kind 
spanning the contiguous US. Residence-based UV exposure is 
a strong predictor of plasma 25(OH)D levels.51 Given the long 
follow-up period of over 24 years, we were able to examine 
a large number of breast cancer cases as well as breast cancer 
subtypes defined by ER status. Using the wealth of informa-
tion collected from NHSII questionnaires as well as linkages of 
geocoded addresses to large-scale objective databases such as 
the U.S. Census Bureau, we were able to evaluate potential con-
founding and effect modification using time-varying informa-
tion on many different known and suspected breast cancer risk 
factors, sun exposure, sensitivity, and protection (e.g., sunburns; 
reaction to the sun; hair color, sunscreen use; time in direct sun-
light; and tanning booth use), and other sources of vitamin D 
including dietary and supplemental vitamin D intake.
Conclusions
Results from this large prospective cohort study of US women 
do not support the hypothesis that higher ambient UV expo-
sure during adulthood reduces the risk of invasive breast cancer 
overall or by ER status. Early-life UV exposure may be inversely 
associated with ER− breast cancer.
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